Latest News
Qol Holdings Co., Ltd.
- Tegoprubart Improves QoL After Kidney Transplant Compared with Tacrolimus, suggests study
- Qol Holdings Co., Ltd. Estimates – TSE:3034
- Adjuvant Giredestrant Preserves QOL With Sustained Tolerability in ER+, HER2– Early Breast Cancer
- Watchful Waiting Has Lasting QOL Benefit in Rectal Cancer
- The Finals Season 12 Preview: A Solo Mode, QoL Changes, and Better Destruction
- Delgocitinib cream improves adolescent chronic hand eczema symptoms and QoL, analyses shows
- Chronicity of Immune-Related AEs Drives QOL Burden With Adjuvant Checkpoint Inhibition in Resected RCC
- Dr Morgans on QOL With Darolutamide in mHSPC
- Control Resonant Update 1.4.0 Patch Notes: New Game++, Performance Fixes, and QoL Improvements
- EADV 2026: Tralokinumab Improves QoL in AD Affecting High-impact Areas
- SBRT Matches Chemoradiation, Preserves QOL Before Pancreatic Surgery
- VPC-Yoga: Structured Yoga Intervention Reduces VPC Burden, Improves QOL
Headlines from the last 30 days, linking to the original publishers. See all market news →